Top Markets
Coin of the day
Roche Holding AG Roche Holding AG

Roche Holding AG

ROG
Rank in Stocks #37
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in... Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. The company was founded in 1896 and is headquartered in Basel, Switzerland.
Share Price
$419.17
Market Cap
$333.66B
Change (1 day)
0.50%
Change (1 year)
14.13%
Country
CH
Trade Roche Holding AG (ROG)

Category

Revenue for Roche Holding AG (ROG)
Revenue in Dec 2025 TTM: $77.52B
According to Roche Holding AG latest financial reports the company's current revenue (TTM) is $77.52B. In 2024 the company made a revenue of $69.07B a decrease compared to the revenue in the year 2023 that was $71.87B. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Roche Holding AG from 2000 to 2026
Revenue at the end of each year
Year Revenue Change
2026 (TTM) $77.52B 0.00%
2025 $77.52B 12.23%
2024 $69.07B -3.89%
2023 $71.87B 0.96%
2022 $71.19B 3.34%
2021 $68.88B 6.09%
2020 $64.93B -1.48%
2019 $65.90B 8.96%
2018 $60.48B 5.74%
2017 $57.20B 10.60%
2016 $51.72B 2.56%
2015 $50.42B 0.45%
2014 $50.20B -7.86%
2013 $54.48B 9.59%
2012 $49.71B 9.80%
2011 $45.28B -10.87%
2010 $50.80B 7.01%
2009 $47.47B 11.15%
2008 $42.71B 4.63%
2007 $40.82B 18.37%
2006 $34.48B 27.80%
2005 $26.98B -1.91%
2004 $27.51B 8.99%
2003 $25.24B 17.44%
2002 $21.49B 22.59%
2001 $17.53B -0.62%
2000 $17.64B 0.00%
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country